Randomized phase II trial to evaluate the effectiveness of azacitidine for low risk MDS

Trial Profile

Randomized phase II trial to evaluate the effectiveness of azacitidine for low risk MDS

Discontinued
Phase of Trial: Phase II

Latest Information Update: 12 May 2016

At a glance

  • Drugs Azacitidine (Primary)
  • Indications Myelodysplastic syndromes
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Jun 2015 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan record.
    • 17 Jan 2014 Status changed from not yet recruiting to recruiting as per University Hospital Medical Information Network - Japan record.
    • 14 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top